Pharmacy and Therapeutics Committee
"Pharmacy and Therapeutics Committee" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An advisory group composed primarily of staff physicians and the pharmacist which serves as the communication link between the medical staff and the pharmacy department.
| Descriptor ID |
D010606
|
| MeSH Number(s) |
N04.452.758.788.682 N05.700.685.625
|
| Concept/Terms |
Committee, Drug- Committee, Drug
- Drug Committees
- Drug Committee
- Committee, Formulary
- Committees, Formulary
- Formulary Committees
- Formulary Committee
- Committee, Pharmacy
- Committees, Pharmacy
- Pharmacy Committee
- Pharmacy Committees
- Committee, Therapeutics
- Committees, Therapeutics
- Therapeutics Committees
- Therapeutics Committee
- Committees, Drug
|
Below are MeSH descriptors whose meaning is more general than "Pharmacy and Therapeutics Committee".
Below are MeSH descriptors whose meaning is more specific than "Pharmacy and Therapeutics Committee".
This graph shows the total number of publications written about "Pharmacy and Therapeutics Committee" by people in this website by year, and whether "Pharmacy and Therapeutics Committee" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pharmacy and Therapeutics Committee" by people in Profiles.
-
Stefanacci RG, Cafiero AC. Antidementia agents: what is important in this class. Manag Care. 2005 May; 14(5 Suppl):11-6.
-
Schrogie JJ. Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Health system perspective regarding glycoprotein IIb/IIIa inhibitor therapy. Am Heart J. 1999 May; 137(5):S126-8.
-
Shulkin DJ, McGourty ME, Bourret J. Involving physicians in efforts to control pharmaceutical expenditures. Med Interface. 1995 Aug; 8(8):85-7, 90.
-
Nash DB, Catalano ML, Wordell CJ. The formulary decision-making process in a US academic medical centre. Pharmacoeconomics. 1993 Jan; 3(1):22-35.
-
Seltzer JL, Wordell CJ, Nash D, Johnson NE, Gottlieb JE. P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion. Hosp Formul. 1992 Apr; 27(4):379-80, 386-92.
-
Nash DB, Johnson NE, Gottlieb JE, Vlasses PH. Monoclonal antibodies for septic shock: in or out of the barn door? QRB Qual Rev Bull. 1991 Oct; 17(10):310-3.